Related references
Note: Only part of the references are listed.SuperPlotsOfData-a web app for the transparent display and quantitative comparison of continuous data from different conditions
Joachim Goedhart
MOLECULAR BIOLOGY OF THE CELL (2021)
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H. Foster et al.
CLINICAL CANCER RESEARCH (2021)
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Sabine A. Hartlieb et al.
NATURE COMMUNICATIONS (2021)
Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
Elmira R. Vagapova et al.
SCIENTIFIC REPORTS (2021)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression
Timothy J. Aikin et al.
ELIFE (2020)
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Davide Cangelosi et al.
CANCERS (2020)
The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin
Ikuo Hirano et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia
Timofey D. Lebedev et al.
FRONTIERS IN ONCOLOGY (2019)
The Evolution of Risk Classification for Neuroblastoma
Elizabeth Sokol et al.
CHILDREN-BASEL (2019)
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
Presha Rajbhandari et al.
CANCER DISCOVERY (2018)
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
Fabio Morandi et al.
ONCOIMMUNOLOGY (2018)
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors
Estelle Daudigeos-Dubus et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
11q deletion in neuroblastoma: a review of biological and clinical implications
Vid Mlakar et al.
MOLECULAR CANCER (2017)
Genetic Variations of GWAS-Identified Genes and Neuroblastoma Susceptibility: a Replication Study in Southern Chinese Children
Jing He et al.
TRANSLATIONAL ONCOLOGY (2017)
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
Zhenghu Chen et al.
ONCOTARGET (2017)
Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
Ivan Petrov et al.
ONCOTARGET (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells
Maria Jose Vazquez-Mellado et al.
LIFE SCIENCES (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Linda J. Valentijn et al.
NATURE GENETICS (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells
Sergi Regot et al.
CELL (2014)
Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling
P. V. Spirin et al.
LEUKEMIA (2014)
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
Charles Wang et al.
NATURE BIOTECHNOLOGY (2014)
An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era
Zhenqiang Su et al.
GENOME BIOLOGY (2014)
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma
L. Calafiore et al.
ANNALS OF ONCOLOGY (2013)
Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem-like Cells to Protect Them from Chemotherapy
Matilde Todaro et al.
CANCER RESEARCH (2013)
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P. Mosse et al.
LANCET ONCOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Shizhen Zhu et al.
CANCER CELL (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software
Lee Kamentsky et al.
BIOINFORMATICS (2011)
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Kai Wang et al.
NATURE (2011)
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
Fran Supek et al.
PLOS ONE (2011)
T-Cell Signaling Regulated by the Tec Family Kinase, Itk
Amy H. Andreotti et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma
Miikka Korja et al.
BMC CANCER (2009)
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
Roberta Vitali et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A multicolor panel of novel lentiviral gene ontology (LeGO) vectors for functional gene analysis
Kristoffer Weber et al.
MOLECULAR THERAPY (2008)
Expression of erythropoietin and its receptor in neuroblastomas
Herve Sartelet et al.
CANCER (2007)
Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang et al.
CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
K Beppu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells
I Stolze et al.
BLOOD (2002)
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma
A Eggert et al.
KLINISCHE PADIATRIE (2000)
Share Paper
